Fair Value Calculator Fair Value Calculator
EN DE

INNOVATIVE (INNOVATIVE) Fair Value & Analysis

IN · Market cap ₹259M

I INNOVATIVE INNOVATIVE · BSE
Price₹22.80
Fair Value₹2.66
Upside-88.3%
Quality47/100
Watch INNOVATIVE for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹2.49 – ₹2.91

Fair value as of: Jul 5, 2026

From 9 valuation models · updated today

Share price −13.3% over the past month.

Price vs Fair Value (12 months)

₹30.40 ₹13.01 Fair Value ₹2.66 Jul 2025 Jul 2026

12‑month range ₹13.01 – ₹30.40 · fair‑value band ₹2.49 – ₹2.91 · the ₹22.80 price screens above the ₹2.66 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

INNOVATIVE (INNOVATIVE) currently trades at ₹22.80, while our model-based Fair Value estimate is ₹2.66 — implying the stock looks roughly 88.3% overvalued today. We read business quality at 47/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Trailing-twelve-month revenue stands at ₹5.4M. Net debt stands at ₹198M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹2.49 (bear case) to ₹2.91 (bull case); at ₹22.80, the current price sits above that range. The share trades about 25% below its 52-week high and 90% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹5.4M
Revenue growth (YoY) -99.7%
Return on equity -269%
Free cash flow ₹448K FY2025
Operating margin -47,685%
EPS (TTM) ₹-8.22
More key figures
Net debt ₹198M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

INNOVATIVE reported revenue of ₹5.4M in FY2025 versus ₹1.6B in FY2021, a compound −75.8%/yr. Reported net income was −₹93.5M in FY2025.

Revenue −75.8%/yr
FY21 ₹1.6B
FY22 ₹1.6B
FY23 ₹1.4B
FY24 ₹1.3B
FY25 ₹5.4M
Net income
FY21 −₹74.5M
FY22 −₹14.3M
FY23 ₹17.9M
FY24 −₹181K
FY25 −₹93.5M

Is INNOVATIVE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "INNOVATIVE Fair Value". https://www.fairvalue-calculator.com/stock/INNOVATIVE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is INNOVATIVE (INNOVATIVE) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹2.66 versus a price of ₹22.80 — about −88% (overvalued). Model-based estimate, not financial advice.
What is the fair value of INNOVATIVE?
Our model-based fair value for INNOVATIVE is ₹2.66 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹22.80.
What is the quality score of INNOVATIVE?
INNOVATIVE has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of INNOVATIVE (INNOVATIVE)?
INNOVATIVE reported trailing-twelve-month revenue of about ₹5.4M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of INNOVATIVE?
The net profit margin of INNOVATIVE is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.